Assyro AI
FDA 483 Database

FDA Form 483s Issued in October 2022

Every published Form FDA 483 issued in October 2022, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.

7

Published 483s in October 2022

7

Distinct firms

Form 483s issued in October 2022

Eli Lilly and CompanyFDA
FEI
1819470
Issued
Oct 21, 2022
Establishment
Finished Pharmaceutical Manufacturer
Location
United States
PQ Pharmacy LLCFDA
FEI
3017374013
Issued
Oct 27, 2022
Establishment
Outsourcing Facility
Location
Florida, United States
Pharmacy Plus, Inc. dba Vital Care CompounderFDA
FEI
3010241801
Issued
Oct 13, 2022
Establishment
Producer of Sterile and Non Sterile Drug Products
Location
Mississippi, United States
QuVa Pharma , Inc.FDA
FEI
3013931875
Issued
Oct 14, 2022
Establishment
Outsourcing Facility
Location
New Jersey, United States
Rx Unlimited PharmacyFDA
FEI
3021032578
Issued
Oct 21, 2022
Establishment
Producer of Sterile and Non Sterile Drug Products
Location
California, United States
Burt's Pharmacy, LLCFDA
FEI
3011924560
Issued
Oct 7, 2022
Establishment
Producer of Non Sterile Drug Products
Location
California, United States
Lupin LimitedFDA
FEI
3010977634
Issued
Oct 14, 2022
Establishment
Active Pharmaceutical Ingredient & Finished Dosage Manufacturer
Location
India

Other months in 2022

Back to the FDA 483 Database